BTIG analyst Ryan Zimmerman maintained a Buy rating on Vicarious Surgical (RBOT – Research Report) yesterday and set a price target of $7.00. The company’s shares closed yesterday at $3.08.
According to TipRanks, Zimmerman is a 5-star analyst with an average return of 9.7% and a 47.87% success rate. Zimmerman covers the Healthcare sector, focusing on stocks such as Intuitive Surgical, Staar Surgical, and Penumbra.
Vicarious Surgical has an analyst consensus of Moderate Buy, with a price target consensus of $7.00.
See Insiders’ Hot Stocks on TipRanks >>
The company has a one-year high of $6.59 and a one-year low of $1.69. Currently, Vicarious Surgical has an average volume of 490.6K.
Based on the recent corporate insider activity of 123 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of RBOT in relation to earlier this year.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
D8 Holdings Corp is a blank check company.
